Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Adamis Pharma (GB:0A4X)
LSE:0A4X
Adamis Pharma (0A4X) Share Price & Analysis
0 Followers
0A4X Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.26 - $35.71
Previous Close$2.26
Volume0.00
Average Volume (3M)137.00
Market Cap
$6.05M
Enterprise Value$3.17M
Total Cash (Recent Filing)$3.13M
Total Debt (Recent Filing)$250.36K
Price to Earnings (P/E)N/A
Beta1.36
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,485,475
10 Day Avg. Volume94
30 Day Avg. Volume137
Standard Deviation0.67
R-Squared0.24
Alpha0.30
Financial Highlights & Ratios
Price to Book (P/B)-0.56
Price to Sales (P/S)665.16
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit-2.22
Enterprise Value/Ebitda-0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Adamis Pharma News
0A4X FAQ
What was Adamis Pharma’s price range in the past 12 months?
Adamis Pharma lowest share price was $2.26 and its highest was $35.71 in the past 12 months.
What is Adamis Pharma’s market cap?
Currently, no data Available
When is Adamis Pharma’s upcoming earnings report date?
Adamis Pharma’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
How were Adamis Pharma’s earnings last quarter?
Adamis Pharma released its earnings results on May 15, 2023. The company reported -$4.2 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.2.
Is Adamis Pharma overvalued?
According to Wall Street analysts Adamis Pharma’s price is currently Overvalued.
Does Adamis Pharma pay dividends?
Adamis Pharma does not currently pay dividends.
What is Adamis Pharma’s EPS estimate?
Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adamis Pharma have?
Currently, no data Available
What happened to Adamis Pharma’s price movement after its last earnings report?
Adamis Pharma reported an EPS of -$4.2 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adamis Pharma?
Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at N/A.
---
Adamis Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.18%
12-Months-Change
Fundamentals
Return on Equity
-784.96%
Trailing 12-Months
Asset Growth
-70.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adamis Pharma
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
---